Feasibility, sensitivity and detection rate of Sentinel Lymph Node Mapping Using hand-held NIR Fluorescence camera with ICG in Early Stage Endometrial Cancer: A pilot study from a tertiary cancer care Center.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Primary
研究概览
简要总结
Significant advances in the surgical management of endometrial cancer are the safe
adoption of minimally invasive surgery and the use of sentinel lymph node(SLN)
mapping through fluorescence-guided minimally invasive surgery. Several trials
comparing the accuracy of SLN, lymphadenectomy or SNL plus lymphadenectomy have
confirmed that SLN is not inferior in identifying nodal disease.Blue dye,
radiotracer 99mTc and Indocyanine green dye (ICG) are commonly explored in
endometrial cancer, and now, recently, sentinel node mapping using indocyanine green
is much assuring.Blue dye is associated with allergic reactions, and radiolabelled tracer is related to many
logistic challenges and costs despite better detection rates. ICG dye is a fluorescent dye
approved by the FDA. It can be lighted with near-infrared fluorescent light and is
extensively used in intra-operative imaging for better anatomic and functional
information. Our institute has recently acquired the IRILIC NIR handheld camera, which
can be used intra-operatively in open surgery.
Study Method
Prospective, open-labeled, non-randomized exploratory intervention trial
The organisation of work elements
Written informed consent will be obtained from patients who fulfil the inclusion criteria
and are willing to participate in the study.
Intraoperative assessment
After anaesthesia, a laparotomy incision will be made midline vertical. After entry into
the peritoneal cavity, peritoneal wash cytology will be taken. A thorough assessment of
abdominal activity will be conducted to rule out any significant lymph nodes or gross
extrauterine disease. SLN mapping will be started after ruling out extrauterine disease.
SLN Mapping
- Intra-cervical injection of ICG at 3 and 9 o’clock positions at concentrations of
1.25mg/ml, submucosally(2-3mm) and deep 1 cm into the stroma, one ml per
injection site. One vial of AUROGREEN ( ICG powder 25mg) will be constituted
with 20 ml of sterile water to obtain the concentration.
- Post injection, room lights are switched off to obtain a dark operating room and
almost immediately, the pelvic spaces will be opened to do sentinel mapping
using the hand-held NIR camera.
- The sentinel nodes are those identified in proximity to the uterus lighted up in
fluorescent green colour on the NIR camera.
- Only lymphatic channels draining to a node are seen, and if the node is not
lightened up, it can also be considered a sentinel node.
- Detected nodes will be sent for a staging procedure in the final histopathological
examination with ultra staging.
- As this is planned as a pilot study, after SLN mapping, irrespective of the dye
uptake, routine lymphadenectomy as indicated for the histology, grade, and stage
will be done, including pelvic and para-aortic lymphadenectomy.
Schedule
After the approval, 20 consecutive cases of carcinoma endometrium fulfilling the
selection criteria and undergoing staging laparotomy will be recruited for the present
study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- Female
入选标准
- •Biopsy confirmed endometrial carcinoma patients with any histology and grade
- •Clinical and radiological (CT/MRI abdomen and pelvis or whole body PET Ct) early stage endometrial carcinoma undergoing staging laparotomy
- •Willingness to be part of the trial.
排除标准
- •Extra uterine disease or those who received neoadjuvant radiation/ chemotherapy for the present disease or those with previous h/o pelvic irradiation or pelvic node dissection for any cause.
结局指标
主要结局
Primary
时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery
1. Evaluation o feasibility of open ICG fluorescent injection technique for SLN mapping in carcinoma endometrium
时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery
2. To detect the sensitivity and specificity, positive and negative predictive values of open SLN testing in carcinoma endometrium.
时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery
Secondary Objective- To analyse the detection rate- unilateral, bilateral and sites of detection
时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery
次要结局
- Secondary Objective- To analyse the detection rate- unilateral, bilateral & sites of detection(Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing)
研究者
Amy Jose
Cancer Institute(WIA) Adyar
